Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 3
1970 10
1971 3
1974 2
1975 2
1977 1
1978 2
1979 3
1980 1
1982 1
1983 4
1984 3
1985 1
1986 3
1987 5
1988 2
1989 1
1991 2
1994 1
1998 1
2001 1
2003 1
2004 1
2008 2
2009 2
2010 1
2011 6
2012 2
2013 9
2014 5
2015 5
2016 8
2017 5
2018 1
2019 2
2020 9
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

105 results
Results by year
Filters applied: . Clear all
Page 1
Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors.
Jaspers JE, Kersbergen A, Boon U, Sol W, van Deemter L, Zander SA, Drost R, Wientjens E, Ji J, Aly A, Doroshow JH, Cranston A, Martin NM, Lau A, O'Connor MJ, Ganesan S, Borst P, Jonkers J, Rottenberg S. Jaspers JE, et al. Among authors: drost r. Cancer Discov. 2013 Jan;3(1):68-81. doi: 10.1158/2159-8290.CD-12-0049. Epub 2012 Oct 25. Cancer Discov. 2013. PMID: 23103855 Free PMC article.
Five pillars for societal perspective.
Drost RMWA, Paulus ATG, Evers SMAA. Drost RMWA, et al. Int J Technol Assess Health Care. 2020 Apr;36(2):72-74. doi: 10.1017/S026646232000001X. Epub 2020 Jan 31. Int J Technol Assess Health Care. 2020. PMID: 32000868
Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin.
Evers B, Drost R, Schut E, de Bruin M, van der Burg E, Derksen PW, Holstege H, Liu X, van Drunen E, Beverloo HB, Smith GC, Martin NM, Lau A, O'Connor MJ, Jonkers J. Evers B, et al. Among authors: drost r. Clin Cancer Res. 2008 Jun 15;14(12):3916-25. doi: 10.1158/1078-0432.CCR-07-4953. Clin Cancer Res. 2008. PMID: 18559613 Free article.
105 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page